Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

News · November 29, 2023

Disease-Modifying Therapy Use for Sickle Cell Remained Low 2014 to 2021

Inconsistent users of DMT had higher prevalence of vaso-occlusive crises, splenic complications, health care visits

HealthDay

 

Further Reading